© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Benorilate, a drug compound blending aspirin (acetylsalicylic acid) and paracetamol (acetaminophen), has seen use as an analgesic and antipyretic. Its chemical formula, C17H15NO5, tells a lot about the underlying properties. The molecular weight comes in at around 313.3 g/mol. This combination’s structure presents an ester linkage bridging the two active components. The physical form can shift between solid powder and crystalline flakes, often showing off a pearly sheen when purified. Some producers offer Benorilate in solid chunk or granular forms designed for easy handling and storage. In the lab, I’ve come across it as off-white crystals, and the density hovers near 1.33 g/cm³—a bit higher than simple aspirin. Benorilate’s melting point tends to land in the range of 104-106°C, not much room for error there, so handling high-purity batches demands attention to temperature shifts.
The ester bond linking salicylate to paracetamol forms the backbone of Benorilate’s molecular structure. This molecular join affects solubility and reactivity. Most samples appear odorless, though prolonged storage in humid environments sometimes gives off faint chemical notes. In a water solution, Benorilate’s solubility remains quite low, less than 0.1 mg/mL at room temperature. Solvents like ethanol or DMSO work better if a higher concentration is needed for experiment runs. Some raw material stocks get shipped as solid, dust-like powders, and in manufacturing environments, flakes or fine pearls reduce clumping during batch mixing. Crystal size can change, but in pharmaceutical prepping, a uniform granule gives the most consistent results.
Globally, Benorilate carries the Harmonized System (HS) Code 29242995, classified among other organic compounds. Pharmaceutical suppliers tend to list the purity, usually above 98%, as a key specification. Shelf life varies with packaging—a dry, air-tight container, kept below 30°C, avoids early degradation. Moisture content creeps up if ambient humidity stays above 60%, so drying agents and sealed storage matter. For a sense of scale: a single gram delivers enough material for thousands of small-dose preparations. The raw material density at room temperature translates well into bulk handling, and the flakes or powder load cleanly into jars or automated dispensers.
Benorilate’s usefulness might tempt complacency, but the safety profile demands respect. Skin and eye contact with the raw material can cause irritation, in my own handling, I always gear up with gloves and goggles without exception. Inhalation of dust over a prolonged period may aggravate respiratory symptoms, especially in poorly ventilated labs. Spills do not react violently with water, but sweep-up and collection must stay thorough due to potential for chemical exposure. Benorilate’s breakdown may generate small amounts of acetic acid vapors, especially near heat, risking mild acid burns in high concentrations. Ingestion of the raw material, as opposed to the tablet formulation, produces stomach distress and liver strain. Chemical disposal requirements get strict: local regulations treat Benorilate residues as hazardous waste, especially due to paracetamol’s documented hepatic toxicity in overdose. For shipping, UN guidance counts Benorilate as a mild health hazard, not flammable or explosive in transit, but corrosive mixed with strong acids or oxidizers.
In pharmaceutical production, Benorilate’s dual action—thanks to its aspirin-paracetamol scaffold—once posed as an attractive way to manage pain and fever. Feedback from healthcare providers, though, curtailed broader use due to potential for Reye’s syndrome in children and possible hepatic toxicity from the paracetamol component in high doses. These warnings drove regulatory changes and labels. Despite risks, for certain patients under careful monitoring, Benorilate offers combined action in a single, controllable formulation. I’ve seen older hospital formularies that list Benorilate as a second-choice antipyretic for adults who don’t tolerate straight aspirin or paracetamol monotherapy.
Handling Benorilate demands a balance between practicality and safety knowledge. The compound’s flake or powder forms streamline transport and formulation, yet every handler from chemist to supply-chain worker faces the task of ensuring clean, safe storage and responsible disposal. The molecular structure gives a predictable profile: non-reactive with neutral materials, mild exothermic reaction near oxidizers, stable at moderate temperature ranges. Those preparing Benorilate-based solutions in the lab count on accurate density, melting point, and purity readings—these markers ensure performance. In the bigger picture, decisions about future use will rest on ongoing safety reviews, improved protective guidelines for manufacturing workers, and more robust labeling to reduce risks of misuse or overexposure. Factual, experience-based knowledge will always stay crucial to keeping products safe both in the lab and in the pharmacy.
